Merck
MRK
$81.71
Share price
-0.13%
Change (1 day)
-35.91%
Change (1 year)
Categories
Merck (MRK) - Total debt
Total debt on the balance sheet as of March 2025 : $34.84 Billion USD
According to Merck's latest financial reports the company's total debt is $34.84 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Merck - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $37.11 B | 5.87% |
| 2023-12-31 | $35.05 B | 14.22% |
| 2022-12-31 | $30.69 B | -7.28% |
| 2021-12-31 | $33.10 B | 4.12% |
| 2020-12-31 | $31.79 B | 20.67% |
| 2019-12-31 | $26.34 B | 4.91% |
| 2018-12-31 | $25.11 B | 2.88% |
| 2017-12-31 | $24.41 B | -1.74% |
| 2016-12-31 | $24.84 B | -5.94% |
| 2015-12-31 | $26.41 B | 23.4% |
| 2014-12-31 | $21.40 B | -14.59% |
| 2013-12-31 | $25.06 B | 21.83% |
| 2012-12-31 | $20.56 B | 17.44% |
| 2011-12-31 | $17.51 B | -2.05% |
| 2010-12-31 | $17.88 B | 2.33% |
| 2009-12-31 | $17.47 B | 180.01% |
| 2008-12-31 | $6.24 B | 8.73% |
| 2007-12-31 | $5.73 B | -16.04% |
| 2006-12-31 | $6.83 B | -15.58% |
| 2005-12-31 | $8.09 B | 17.82% |
| 2004-12-31 | $6.87 B | 1.13% |
| 2003-12-31 | $6.79 B | -20.5% |
| 2002-12-31 | $8.54 B | -3.57% |
| 2001-12-31 | $8.86 B | 28.11% |
| 2000-12-31 | $6.92 B | 15.28% |
| 1999-12-31 | $6.00 B | 56.12% |
| 1998-12-31 | $3.84 B | 70.96% |
| 1997-12-31 | $2.24 B | 27.64% |
| 1996-12-31 | $1.76 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $61.29 B | 75.90% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $52.25 B | 49.96% | 🇺🇸 USA |
 Eli Lilly LLY | $38.51 B | 10.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $51.23 B | 47.05% | 🇺🇸 USA |
 Sanofi SNY | $22.78 B | -34.62% | 🇫🇷 France |
 GlaxoSmithKline GSK | $23.84 B | -31.56% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $16.93 B | -51.39% | 🇮🇱 Israel |
 Novartis NVS | $31.27 B | -10.26% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $13.24 B | -62.00% | 🇺🇸 USA |
 Amgen AMGN | $57.38 B | 64.68% | 🇺🇸 USA |